Schonfeld Strategic Advisors LLC Adma Biologics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $89,078 - $166,537	14,896 New	14,896 $166,000
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $241,840 - $327,104	-77,513 Reduced 72.89%	28,835 $106,000
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $769,852 - $989,810	-255,765 Reduced 70.63%	106,348 $352,000
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $1.18 Million - $1.85 Million	-476,353 Reduced 56.81%	362,113 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $446,955 - $629,700	-220,175 Reduced 20.8%	838,466 $2.04 Million
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $258,851 - $398,233	-181,015 Reduced 14.6%	1,058,641 $2.1 Million
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $715,484 - $1.02 Million	558,972 Added 82.12%	1,239,656 $2.27 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $659,105 - $1 Million	604,684 Added 795.64%	680,684 $960,000
Q3 2021 Nov 16, 2021	SELL	$1.13 - $1.65 $413,436 - $603,690	-365,873 Reduced 82.8%	76,000 $86,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $378,125 - $518,356	-250,414 Reduced 36.17%	441,873 $707,000
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $198,252 - $350,206	118,714 Added 20.7%	692,287 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $284,670 - $404,864	-158,150 Reduced 21.61%	573,573 $1.12 Million
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $295,404 - $541,574	144,806 Added 24.67%	731,723 $2,000
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $330,354 - $449,117	-136,510 Reduced 18.87%	586,917 $1.72 Million
Q1 2020 May 15, 2020	SELL	$1.5 - $4.59 $776,049 - $2.37 Million	-517,366 Reduced 41.7%	723,427 $2.08 Million
Q4 2019 Feb 14, 2020	SELL	$3.89 - $5.15 $1.28 Million - $1.7 Million	-329,615 Reduced 20.99%	1,240,793 $4.96 Million
Q3 2019 Nov 14, 2019	SELL	$3.19 - $5.39 $1.9 Million - $3.21 Million	-595,992 Reduced 27.51%	1,570,408 $6.99 Million
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $6.83 Million - $10.2 Million	1,941,400 Added 862.84%	2,166,400 $8.38 Million
Q1 2019 May 15, 2019	BUY	$2.61 - $4.35 $587,250 - $978,749	225,000 New	225,000 $853,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

185M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.91B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account